Pharmaceutical Technology

AUGUST 7, 2025

mRNA technology was accelerated in 2020 due to the modality being central to all Covid vaccinations. mRNA vaccine coverage on Pharmaceutical Technology (or Clinical Trials Arena) is supported by Trilink. Shares of key sector players such as Moderna and BioNTech remain stable, with values reducing by 2.8%

Insurance Coverage and Processing

pharmaphorum

JANUARY 28, 2021

In 2020, we saw seven of the 20 biosimilars currently available in the US launch. The United States biosimilar market experienced a significant increase in competition in 2020. As a result of the regulatory changes that occurred in March 2020, the first potential insulin biosimilar is on the horizon. million patients.

Biosimilars

pharmaphorum

APRIL 29, 2021

To say that Kaia Health has had a busy 2020 is an understatement. Officially launched in 2016, Kaia’s technology can now be accessed by 60 million patients worldwide and it claims to be the biggest player in digital MSK in terms of coverage. The benefits of insurance firms are focused on main HQ offices.”. About the author.

Insurance Coverage and Processing

Putting Patients First Blog

JANUARY 10, 2024

Making available more specific information about total costs and coverage will ensure that all consumers have comprehensive information to help them make smart health care decisions. These resources should aim to clarify insurance terms and concepts, aiding consumers in navigating the complexities of selecting a health plan.

Insurance Coverage and Processing

pharmaphorum

NOVEMBER 1, 2022

In January 2020, the financial conglomerate Visa announced it was acquiring a relatively unknown startup, Plaid, for $5.3 Corporate acquisitions like these are not uncommon, but someone at the United States Department of Justice took notice of this announcement. Visa had established a stranglehold on financial transactions.

HIPAA

Pharmaceutical Technology

NOVEMBER 30, 2022

In the US, most private health insurers have been slow to cover the cost of anti-obesity therapeutics. Medicare Part A, Part B, and Part D do not generally cover approved weight loss medications like Saxenda, but Medicare Advantage plans may allow for expanded coverage, as per the Medicare.org site.

Insurance Coverage and Processing

The Thyroid Pharmacist

AUGUST 4, 2023

4] One of the key things to note is that this gene variation also prevents people from properly methylating, which is one of the body’s key detox processes that helps them get rid of toxins. But a 2020 study of 34 women with hypothyroidism actually found that the MTHFR gene variant is significantly associated with hypothyroidism. [11]

Insurance Coverage and Processing

Pharmaceutical Technology

NOVEMBER 30, 2022

In the US, most private health insurers have been slow to cover the cost of anti-obesity therapeutics. Medicare Part A, Part B, and Part D do not generally cover approved weight loss medications like Saxenda, but Medicare Advantage plans may allow for expanded coverage, as per the Medicare.org site.

Insurance Coverage and Processing

Putting Patients First Blog

MARCH 4, 2024

Ensure Comprehensive Transparency in Formulary Management: Provide clear, comprehensive guidelines to Part D plans to ensure transparency in plan coverage, tiering, and utilization management (UM) policies, offering safeguards against practices that could restrict access to necessary treatments.

Insurance Coverage and Processing

Proxsys Rx

APRIL 4, 2024

According to a report by The American Hospital Association , the number of Americans with chronic medical conditions will grow by a projected 9% between 2020 and 2030, an increase of 14 million people. Payers and manufacturers control the players in Specialty, so newcomers need significant support and guidance navigating the process.

Specialty Pharmacies

Proxsys Rx

AUGUST 22, 2023

According to a report by The American Hospital Association , the number of Americans with chronic medical conditions will grow by a projected 9% between 2020 and 2030, an increase of 14 million people. Payers and manufacturers control the players in Specialty, so newcomers need significant support and guidance navigating the process.

Specialty Pharmacies

Putting Patients First Blog

JULY 2, 2024

We believe that patient-centric engagement is essential to ensure that the negotiation process leads to outcomes that genuinely benefit patients. Patient Engagement The NHC recognizes and commends CMS’ willingness to improve the listening sessions and the data submission processes. Improving the Data Collection (ICR) Process.

Drug Pricing

Putting Patients First Blog

JANUARY 27, 2025

Coverage of Anti-Obesity Medications (AOMs) The NHC applauds CMS for aligning with the medical community and proposing to recognize obesity as a chronic disease and allow Medicare Part D coverage for AOMs. Below, we provide detailed comments and recommendations on key provisions of the proposed rule.

Insurance Coverage and Processing

Putting Patients First Blog

MARCH 4, 2024

Under the new Manufacturer Discount Program, manufacturers will be required to provide discounts on applicable drugs during the initial coverage phase and catastrophic phase of the defined standard Part D drug benefit.

Insurance Coverage and Processing

Proxsys Rx

DECEMBER 22, 2023

According to a report by The American Hospital Association , the number of Americans with chronic medical conditions will grow by a projected 9% between 2020 and 2030, an increase of 14 million people. Payers and manufacturers control the players in Specialty, so newcomers need significant support and guidance navigating the process.

Specialty Pharmacies

Putting Patients First Blog

JULY 15, 2024

Too often the formal notice and comment process does not reach these marginalized communities and federal agencies must actively work to seek their input in non-traditional ways. This process respects their autonomy by involving them in decision-making to the extent that they are able.

Health and Personal Care Stores

PharmaShots

JUNE 28, 2023

In 2020 and 2021, this decrease was driven by lower net selling price, unit demand, and unfavorable changes in inventory, partially offset by favorable changes to estimated sales deductions and inventory.

Biosimilars

Express Pharma

JANUARY 12, 2024

Due to the multiplicity of regulatory processes and multiple regulators, undertaking operations become complex and time consuming. IRDAI has included the health insurance coverage for 12 such modern treatment methods under Chapter V of the Guidelines on “Standardisation of exclusions in health insurance contracts”.

Insurance Coverage and Processing

The Happy PharmD

MARCH 13, 2025

UHGs journey started in 1974 as Charter Med Incorporated, just another claims-processing operation. in 2020 to 22% in 2022. And those numbers dont even touch private plans, where insurers are notorious for keeping denial data hidden. And lets not forget the growing denial rates. Thats double. UHG isnt slowing down.

Insurance Coverage and Processing

Pharmaceutical Technology

MAY 26, 2023

Even before this shortage was announced, a 2020 study found that approximately 98% of online pharmacies selling Adderall were rogue or unclassified. Mackey says that people may seek medications due to issues with health insurance policies, variable coverage for certain conditions, lack of access, and more.

Online Pharmacies

The Thyroid Pharmacist

JULY 28, 2023

I’ll specify which tests are usually covered on insurance if you have a willing practitioner that can bill insurance, which tests can be self-ordered and then submitted to insurance, and which ones are usually an out-of-pocket expense that you may need to save for. You can use Health Savings Accounts for most.)

Insurance Coverage and Processing

Putting Patients First Blog

NOVEMBER 12, 2024

General Support for CMS Proposals The NHC commends CMS for its ongoing commitment to advancing health equity, improving access to care, ensuring program integrity, and maintaining affordability through Marketplace coverage. Copay Assistance and Drug Coverage in Large Group Plans Accumulator Adjustment Programs and Cost Sharing.

Insurance Coverage and Processing

Putting Patients First Blog

SEPTEMBER 9, 2024

16 We encourage CMS to continue refining these data collection processes to ensure they capture meaningful and actionable information. We believe this process is crucial for adapting the payment system to evolving clinical practices and emerging medical technologies.

Insurance Coverage and Processing

Putting Patients First Blog

MARCH 29, 2023

Provisions to Ensure Coverage During Future PHEs The pandemic has underscored the importance of meaningful, affordable health insurance coverage. Making sure that the greatest number of people possible have coverage during a PHE is critical to assuring that patients and our health care system are protected during a PHE.

Insurance Coverage and Processing

Putting Patients First Blog

SEPTEMBER 9, 2024

As these technologies become increasingly integral to patient care, it is essential for CMS to develop clear and consistent guidelines for the payment and coverage of AI-enabled services. Providing clear guidance, technical assistance, and streamlined processes can help facilitate the adoption of this innovative care model.

Insurance Coverage and Processing

Proxsys Rx

AUGUST 16, 2023

In fact, the report found, 340B DSH hospitals provided $41 billion in uncompensated care in 2020 alone. In 2020, the average 340B DSH hospital provided $38 million in uncompensated care — while the average non-340B hospital provided just over $14 million… … Why did the manufacturers impose 340B discount restrictions?

Insurance Coverage and Processing